Results of the use of antioxidant and angioprotective agents in type 2 diabetes patients with diabetic retinopathy and age-related macular degeneration
to investigate changes in clinical, functional, and morphological parameters of the retina in type 2 diabetes patients with diabetic retinopathy (DR) and those with combined fundus pathology (DR plus age-related macular degeneration (AMD)) before and after a course of antioxidants and angioprotector...
Saved in:
Published in | Vestnik oftal'mologii Vol. 131; no. 3; p. 34 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | Russian |
Published |
Russia (Federation)
01.05.2015
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | to investigate changes in clinical, functional, and morphological parameters of the retina in type 2 diabetes patients with diabetic retinopathy (DR) and those with combined fundus pathology (DR plus age-related macular degeneration (AMD)) before and after a course of antioxidants and angioprotectors in the form of mono- or combination therapy.
The study included 180 patients (180 eyes) with type 2 diabetes divided into 6 groups of 30 each. DR was graded according to E. Kohner and M. Porta classification, AMD--AREDS classification. Thus, group 1 consisted of patients with DRO,; group 2--DR1 without DM, group 3--DR1 with DM, group 4--DRO and "dry" AMD (AREDS 1-3), group 5--DR1 with no DM but with AMD (AREDS 1-3), and group 6--DR1 with DM and AMD (AREDS 1-3). A drug containing lutein 6 mg, zeaxanthin 0.5 mg, vitamin C 60 mg, vitamin E 7 mg, vitamin A 1.5 mg, vitamin B2 1.2 mg, rutin 25 mg, zinc 5 mg, selenium 25 mcg, and bilberry extract 60 mg was used for antioxidative therapy. Ginkgo biloba leaf extract 60 mg was chosen as the angioprotector. In all patients visual acuity, macular thickness and morphology (OCT) as well as light sensitivity (microperimetry) were assessed before and after the treatment course.
Analysis of baseline measurements demonstrated a significant decrease in best corrected visual acuity (p < 0.05) in study groups 2-6 as compared with group 1. Macular thickness was increased in all groups, however, the changes were statistically significant only in groups 3 and 6 (p<0.05). Light sensitivity of the macula showed a reduction, which was statistically significant in groups 4-6 (p < 0.05). After the course of antioxidant and angioprotective therapy, these parameters improved in all groups. The greatest effect was achieved with simultaneous antioxidant and double-dose angioprotective therapy (240 mg per day): visual acuity increased significantly (p < 0.05) in all groups except group 1; macular thickness decreased in all groups, however, the changes were statistically significant (p < 0.05) only in groups 1-3 and 5; light sensitivity also improved in all groups, significantly (p < 0.05) in groups 1-3 and 4.
Extended analysis of clinical, functional and morphological changes in the retina at the onset of DR in type 2 diabetes patients with concomitant "dry" AMD enables timely diagnosis, prognosis, prevention, and early treatment. Conservative treatment with antioxidant and angioprotective agents has been proved effective in type 2 diabetes patients with preclinical (DRO) and early (DR1) diabetic retinopathy and those with DR and "dry" AMD (AREDS 1-3) in terms of functional and morphological parameters of the retina. From all the regimens, a combined antioxidant and double-dose angioprotective (240 mg) therapy appeared to be the most effective and can be considered not only a preventive, but also a therapeutic measure in type 2 diabetes patients with initial stages of DR (DRO, DR1) or those with DR and DM or combined DR and AMD (AREDS 1-3). |
---|---|
AbstractList | to investigate changes in clinical, functional, and morphological parameters of the retina in type 2 diabetes patients with diabetic retinopathy (DR) and those with combined fundus pathology (DR plus age-related macular degeneration (AMD)) before and after a course of antioxidants and angioprotectors in the form of mono- or combination therapy.
The study included 180 patients (180 eyes) with type 2 diabetes divided into 6 groups of 30 each. DR was graded according to E. Kohner and M. Porta classification, AMD--AREDS classification. Thus, group 1 consisted of patients with DRO,; group 2--DR1 without DM, group 3--DR1 with DM, group 4--DRO and "dry" AMD (AREDS 1-3), group 5--DR1 with no DM but with AMD (AREDS 1-3), and group 6--DR1 with DM and AMD (AREDS 1-3). A drug containing lutein 6 mg, zeaxanthin 0.5 mg, vitamin C 60 mg, vitamin E 7 mg, vitamin A 1.5 mg, vitamin B2 1.2 mg, rutin 25 mg, zinc 5 mg, selenium 25 mcg, and bilberry extract 60 mg was used for antioxidative therapy. Ginkgo biloba leaf extract 60 mg was chosen as the angioprotector. In all patients visual acuity, macular thickness and morphology (OCT) as well as light sensitivity (microperimetry) were assessed before and after the treatment course.
Analysis of baseline measurements demonstrated a significant decrease in best corrected visual acuity (p < 0.05) in study groups 2-6 as compared with group 1. Macular thickness was increased in all groups, however, the changes were statistically significant only in groups 3 and 6 (p<0.05). Light sensitivity of the macula showed a reduction, which was statistically significant in groups 4-6 (p < 0.05). After the course of antioxidant and angioprotective therapy, these parameters improved in all groups. The greatest effect was achieved with simultaneous antioxidant and double-dose angioprotective therapy (240 mg per day): visual acuity increased significantly (p < 0.05) in all groups except group 1; macular thickness decreased in all groups, however, the changes were statistically significant (p < 0.05) only in groups 1-3 and 5; light sensitivity also improved in all groups, significantly (p < 0.05) in groups 1-3 and 4.
Extended analysis of clinical, functional and morphological changes in the retina at the onset of DR in type 2 diabetes patients with concomitant "dry" AMD enables timely diagnosis, prognosis, prevention, and early treatment. Conservative treatment with antioxidant and angioprotective agents has been proved effective in type 2 diabetes patients with preclinical (DRO) and early (DR1) diabetic retinopathy and those with DR and "dry" AMD (AREDS 1-3) in terms of functional and morphological parameters of the retina. From all the regimens, a combined antioxidant and double-dose angioprotective (240 mg) therapy appeared to be the most effective and can be considered not only a preventive, but also a therapeutic measure in type 2 diabetes patients with initial stages of DR (DRO, DR1) or those with DR and DM or combined DR and AMD (AREDS 1-3). |
Author | Moshetova, L K Mikhaleva, L G Vorob'eva, I V Alekseev, I B |
Author_xml | – sequence: 1 givenname: L K surname: Moshetova fullname: Moshetova, L K organization: Russian Medical Academy of Postgraduate Education, Ophthalmology Department, Ministry of Health of the Russian Federation, 2/1 Barrikadnaya St., Moscow, Russian Federation, 123242, City Clinical Hospital named after S.P. Botkin, Branch #1, Moscow Health Department, 7 Mamonovskiy pereulok, Moscow, Russian Federation, 123001 – sequence: 2 givenname: I V surname: Vorob'eva fullname: Vorob'eva, I V organization: Russian Medical Academy of Postgraduate Education, Ophthalmology Department, Ministry of Health of the Russian Federation, 2/1 Barrikadnaya St., Moscow, Russian Federation, 123242, City Clinical Hospital named after S.P. Botkin, Branch #1, Moscow Health Department, 7 Mamonovskiy pereulok, Moscow, Russian Federation, 123001 – sequence: 3 givenname: I B surname: Alekseev fullname: Alekseev, I B organization: Russian Medical Academy of Postgraduate Education, Ophthalmology Department, Ministry of Health of the Russian Federation, 2/1 Barrikadnaya St., Moscow, Russian Federation, 123242, City Clinical Hospital named after S.P. Botkin, Branch #1, Moscow Health Department, 7 Mamonovskiy pereulok, Moscow, Russian Federation, 123001 – sequence: 4 givenname: L G surname: Mikhaleva fullname: Mikhaleva, L G organization: Russian Medical Academy of Postgraduate Education, Ophthalmology Department, Ministry of Health of the Russian Federation, 2/1 Barrikadnaya St., Moscow, Russian Federation, 123242, City Clinical Hospital named after S.P. Botkin, Branch #1, Moscow Health Department, 7 Mamonovskiy pereulok, Moscow, Russian Federation, 123001 |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26310005$$D View this record in MEDLINE/PubMed |
BookMark | eNo1kE1OwzAQhb0ooqX0CCBfIGA7tpMuUcWfhISEQGJXTexJa5TEkeMAPQnXxaVlMTNP72m-xTsjk853SMgFZ1e84Fxf-zpC04JgXPGc57nMpJyQGWNSZFKr9ylZDMMHY4xLpXmhT8lU6JwnQ83IzwsOYxMH6msat0jHAfcSuuj8t7PpJm3TbJzvg49oovtEChvs0pPraNz1SAW1DiqMONAeovvLvlzcHm1naEi78ync7g7ADWYBG4hoaQtmbCBQi4mKIQF8d05OamgGXBzvnLzd3b6uHrKn5_vH1c1TZkTBZVZWti5NAUtdl7VhRsjCCmmqZOelRSM4SK6WoJQuBKukrAFMEst9UUpVYk4uD9x-rFq06z64FsJu_d-Q-AWDI28P |
CitedBy_id | crossref_primary_10_3390_ijms21155563 crossref_primary_10_1016_j_brainresbull_2017_06_001 crossref_primary_10_3892_mco_2017_1520 crossref_primary_10_1111_bph_13625 crossref_primary_10_12677_HJO_2018_71004 crossref_primary_10_21516_2072_0076_2019_12_1_81_85 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.17116/oftalma2015131334-44 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
ExternalDocumentID | 26310005 |
Genre | English Abstract Journal Article |
GroupedDBID | .GJ 53G ALMA_UNASSIGNED_HOLDINGS CGR CUY CVF ECM EIF F5P NPM SV3 VCL VIT VME |
ID | FETCH-LOGICAL-c2714-8bdf8c7a96f8fc0c247d24cbbdf38dec21a4159a556720b44faac20b9313355b2 |
ISSN | 0042-465X |
IngestDate | Sat Sep 28 08:01:41 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | Russian |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c2714-8bdf8c7a96f8fc0c247d24cbbdf38dec21a4159a556720b44faac20b9313355b2 |
OpenAccessLink | https://doi.org/10.17116/oftalma2015131334-44 |
PMID | 26310005 |
ParticipantIDs | pubmed_primary_26310005 |
PublicationCentury | 2000 |
PublicationDate | 2015-05-01 |
PublicationDateYYYYMMDD | 2015-05-01 |
PublicationDate_xml | – month: 05 year: 2015 text: 2015-05-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Russia (Federation) |
PublicationPlace_xml | – name: Russia (Federation) |
PublicationTitle | Vestnik oftal'mologii |
PublicationTitleAlternate | Vestn Oftalmol |
PublicationYear | 2015 |
SSID | ssj0001456176 |
Score | 2.072774 |
Snippet | to investigate changes in clinical, functional, and morphological parameters of the retina in type 2 diabetes patients with diabetic retinopathy (DR) and those... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 34 |
SubjectTerms | Aged Angiogenesis Inhibitors - therapeutic use Antioxidants - therapeutic use Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Diabetic Retinopathy - complications Diabetic Retinopathy - diagnosis Diabetic Retinopathy - drug therapy Drug Therapy, Combination Female Fluorescein Angiography Follow-Up Studies Fundus Oculi Humans Macular Degeneration - complications Macular Degeneration - diagnosis Macular Degeneration - drug therapy Male Tomography, Optical Coherence Treatment Outcome |
Title | Results of the use of antioxidant and angioprotective agents in type 2 diabetes patients with diabetic retinopathy and age-related macular degeneration |
URI | https://www.ncbi.nlm.nih.gov/pubmed/26310005 |
Volume | 131 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELa2cOGCQLwpyAeuhsbxI3usUKEg2gNqq71VtmNvo3aTqptFVf8If6c_reNHHl2KeFwiy44miefTeDz5ZozQO1iDneNMEMfFlDAhHCmslYRaXjiWw4Yi1O7c2xe7h-zrjM8mk-sRa2nV6vfm6s68kv_RKvSBXn2W7D9othcKHdAG_cIVNAzXv9Lxd7tcnUUyhvcfVzEurzyB8bIqVWKPq3peNakeg-cJqXnIavMEx7X4ayqymjLeYnco8dxWdePPLo7FmkAACTkw4KwuVCSylnYeClj3ek4O7xGsOnXl2eutP1pALoKxrXo9N8sT2zY_ggv7bYi5HjUXjYbbbRz5MnBxt8_s6dLCTIXu_ofRXnV6AmtdJ-jzOJqR8YE72FloRgEyfHbLQufZCIr5yN7GQOgvy4DMQkgifNpC-eeAiDxnhN26H7R5vgjYoCL86OB_Hl2rzt0NbaANWXgLu5-iRSHG573TcL5h_1kpicy_4Ie7Xs8Xp04i1zY6weE5eIQepp0K3o6we4wmF6sn6GeCHG4cBshhgJxvjiAH7RKvQQ5HyOGqxh5ymOIOcriDHPaQwx3k8AhyUeAAOZwgh8eQe4oOP-0cfNwl6WwPYqjMGCl06Qoj1VS4wpktQ5ksKTMauvOitIZmClzLqeJcSLqlGXPKFxPVUz9RnGv6DN2rm9q-QFgXRmhnGQPTwnKRq1yXYHik0yIzRrCX6Hmcx-PzWMDluJvhV78deY0eDOjcRPcdWAz7BtzPVr8NOr4B8zSIbA |
link.rule.ids | 786 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Results+of+the+use+of+antioxidant+and+angioprotective+agents+in+type+2+diabetes+patients+with+diabetic+retinopathy+and+age-related+macular+degeneration&rft.jtitle=Vestnik+oftal%27mologii&rft.au=Moshetova%2C+L+K&rft.au=Vorob%27eva%2C+I+V&rft.au=Alekseev%2C+I+B&rft.au=Mikhaleva%2C+L+G&rft.date=2015-05-01&rft.issn=0042-465X&rft.volume=131&rft.issue=3&rft.spage=34&rft_id=info:doi/10.17116%2Foftalma2015131334-44&rft_id=info%3Apmid%2F26310005&rft_id=info%3Apmid%2F26310005&rft.externalDocID=26310005 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0042-465X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0042-465X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0042-465X&client=summon |